Morgan Stanley »

Kalaris Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $5.2k 2.0k 2.67

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Kalaris Therapeutics

Samsara BioCapital
Tang Capital Management
Siren
Woodline Partners
Vanguard Group
Renaissance Technologies
Redmile Group
Geode Capital Management
BlackRock
Squarepoint Ops
Fortis Capital Advisors
Belpointe Asset Management
Millennium Management
State Street Corporation
Bridgeway Capital Management

View all funds holding Kalaris Therapeutics